The Rhetoricity of What? Theses on Philosophy and Rhetoric
Philosophy & Rhetoric · 22.07.2026 · 58 (4) · 469-477
DOI: 10.5325/philrhet.58.4.0469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Philosophy & Rhetoric, erschienen am 22.07.2026. Verfasst von Blake D. Scott. Die Arbeit nennt 1 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
This article outlines a way of thinking about rhetoric that avoids the usual worries philosophers have about their long-standing rivals. The author’s proposal for philosophers to consider is that the object of rhetoric—what rhetoric is about—is a particular aspect or dimension of all discourse called “rhetoricity.” Where most philosophers who engage with rhetoric end up typologizing discourse, that is, making a distinction in kind between rhetorical and non-rhetorical ways of acting, the article argues that there is a certain rhetoricity to every instance of discourse—including the discourse of philosophers. To adopt a rhetorical perspective on discourse is thus to recognize that all discourse has a determinate addressive character; it is to recognize that discourse, regardless of medium, constructs its audience in some particular way before being taken up by any particular addressee. The main advantage of this view for philosophers is that it avoids pitting rhetorical considerations against ethical and epistemological ones.
Förderung
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Scott, B. D. (2026). The Rhetoricity of What? Theses on Philosophy and Rhetoric. Philosophy & Rhetoric, 58(4), 469-477. https://doi.org/10.5325/philrhet.58.4.0469
Vancouver
Scott BD. The Rhetoricity of What? Theses on Philosophy and Rhetoric. Philosophy & Rhetoric. 2026;58(4):469-477. doi:10.5325/philrhet.58.4.0469
BibTeX
@article{Scott2026,
author = {Scott, Blake D.},
title = {The Rhetoricity of What? Theses on Philosophy and Rhetoric},
journal = {Philosophy & Rhetoric},
year = {2026},
volume = {58},
number = {4},
pages = {469--477},
doi = {10.5325/philrhet.58.4.0469}
}
EUVIMED